InsidersTradesSigma
Follow the Piramal Pharma share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €289.6bn. The latest transaction was disclosed on 6 August 2026 (Disposal). Among the most active insiders: HDFC Mutual Fund. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Piramal Pharma is a pharmaceutical company focused on the development of medicines and health solutions. It is part of the Piramal Group, which operates in various sectors including health and wellness.